Vimarsana
Biggest News Aggregation in the World

Page 2 - Physiomimic Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Physiomimic Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Physiomimic Technology Today - Breaking & Trending Today

Relief Therapeutics to Present Pre-Clinical Evidence for Improved Amino Acid Utilization with PKU GO - Vimarsana News

Relief Therapeutics to Present Pre-Clinical Evidence for Improved Amino Acid Utilization with PKU GO

Relief Therapeutics Holding SA / Key word(s): Study results17-March-2023 / 22:45 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Relief Therapeutics to Present Pre-Clinical Evidence for Improved Amino Acid Utilization with PKU GOLI...

Relief Therapeutics to Present Pre-Clinical Evidence for Improved Amino Acid Utilization with PKU GOLIKE at the Society for Inherited Metabolic Disorders 44th Annual Meeting - Vimarsana News

Relief Therapeutics to Present Pre-Clinical Evidence for Improved Amino Acid Utilization with PKU GOLIKE at the Society for Inherited Metabolic Disorders 44th Annual Meeting

17.03.2023 - Relief Therapeutics Holding SA / Key word(s): Study results Relief Therapeutics to Present Pre-Clinical Evidence for Improved Amino Acid Utilization with PKU GOLIKE at the Society for Inherited Metabolic Disorders 44th Annual Meeting 17-March-2023 ... Seite 1

Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Announces Issuance of Shares from Authorized Capital - Vimarsana News

Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Announces Issuance of Shares from Authorized Capital

Relief Therapeutics Holding SA / Key word(s): Capital Increase Relief Therapeutics Announces Issuance of Shares from Authorized Capital 13-Dec-2022 / 07:00 CET/CEST Release of an ad hoc announcement

Relief Therapeutics Holding SA: APR Applied Pharma Research (a Subsidiary of Relief Therapeutics) is a Finalist in the 2022 Rare Disease International Film Festival - Vimarsana News

Relief Therapeutics Holding SA: APR Applied Pharma Research (a Subsidiary of Relief Therapeutics) is a Finalist in the 2022 Rare Disease International Film Festival

Relief Therapeutics Holding SA / Key word(s): Miscellaneous APR Applied Pharma Research (a Subsidiary of Relief Therapeutics) is a Finalist in the 2022 Rare Disease International Film Festival

Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Announces Promotion of Paolo Galfetti to Chief Operating Officer - Vimarsana News

Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Announces Promotion of Paolo Galfetti to Chief Operating Officer

Relief Therapeutics Holding SA / Key word(s): Personnel Relief Therapeutics Announces Promotion of Paolo Galfetti to Chief Operating Officer 14-Oct-2022 / 07:00 CET/CEST Release of an ad hoc announcement